title: Characterization of secondary GI lesions with anaplastic large-cell (Ki-1) lymphoma: a first report of two cases.
authors.affiliation: Division of Gastroenterology, Department of Internal Medicine, Kawaski Medical School, Okayama, Japan.
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Matsumoto
authors.forename: Hideki
authors.initials: H
authors.lastname: Koga
authors.forename: Keisuke
authors.initials: K
authors.lastname: Honda
authors.forename: Yoshito
authors.initials: Y
authors.lastname: Sadahira
authors.forename: Yoshimasa
authors.initials: Y
authors.lastname: Suetugu
authors.forename: Makoto
authors.initials: M
authors.lastname: Mikami
authors.forename: Hidekazu
authors.initials: H
authors.lastname: Nakanishi
authors.forename: Ken-ichirou
authors.initials: K
authors.lastname: Yata
authors.forename: Hideho
authors.initials: H
authors.lastname: Wada
authors.forename: Takashi
authors.initials: T
authors.lastname: Sugihara
authors.forename: Ken
authors.initials: K
authors.lastname: Haruma
mesh_terms: D000328:Adult; D000077548:Anaplastic Lymphoma Kinase; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D004317:Doxorubicin / Q000627:therapeutic use; D005260:Female; D005770:Gastrointestinal Neoplasms / Q000188:drug therapy / Q000201:enzymology* / Q000473:pathology*; D006801:Humans; D017728:Lymphoma, Large-Cell, Anaplastic / Q000188:drug therapy / Q000201:enzymology* / Q000473:pathology*; D011239:Prednisolone / Q000627:therapeutic use; D011505:Protein-Tyrosine Kinases / Q000378:metabolism*; D020794:Receptor Protein-Tyrosine Kinases; D014750:Vincristine / Q000627:therapeutic use
chemical_list: D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011239:Prednisolone; C000626173:ALK protein, human; D000077548:Anaplastic Lymphoma Kinase; D011505:Protein-Tyrosine Kinases; D020794:Receptor Protein-Tyrosine Kinases